Turkish Journal of Medical Sciences
Volume 36

Number 6

Article 7

1-1-2006

Cardioembolic Strokes in Eastern Iran and the Importance of
Rheumatic Valvular Disease
KAVIAN GHANDEHARI
ZAHRA IZADI MOOD

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
GHANDEHARI, KAVIAN and MOOD, ZAHRA IZADI (2006) "Cardioembolic Strokes in Eastern Iran and the
Importance of Rheumatic Valvular Disease," Turkish Journal of Medical Sciences: Vol. 36: No. 6, Article 7.
Available at: https://journals.tubitak.gov.tr/medical/vol36/iss6/7

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

ORIGINAL ARTICLE

Kavian GHANDEHARI1
Zahra IZADI MOOD2

Turk J Med Sci
2006; 36 (6): 361-364
© TÜB‹TAK
E-mail: medsci@tubitak.gov.tr

Cardioembolic Strokes in Eastern Iran and the
Importance of Rheumatic Valvular Disease
Background: Rheumatic valvular disease is a common complication of rheumatic fever in children in
developing countries. Later in life, rheumatic valvular disease becomes an important modifiable risk factor of
stroke. The incidence of rheumatic valvular disease and its complications are unknown in Iran.
Materials and Methods: This is a prospective study of 302 consecutive patients admitted to a tertiary care
hospital in Iran with a diagnosis of non-hemorrhagic stroke from June 2003 to June 2005. All patients
underwent diagnostic work-up to determine stroke etiology according to clinical indications. Diagnosis and
classification of stroke were made according to World Health Organization (WHO) criteria.
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Results: In 302 patients with stroke (mean age 66.78, SD: 14.36), 60 (20%) patients (mean age 65.61, SD:
17.48) had cardiac source of embolism (CSE). Rheumatic mitral stenosis was present in 28 (28/60; 46.6%)
of these cardioembolic stroke patients. Atrial fibrillation was documented in 19 (67.8%) patients with mitral
stenosis. The remaining 32 (32/60; 53.3%) cardioembolic stroke patients had other CSE. Among the latter
group, 8 (25%) patients had non-valvular atrial fibrillation. In the entire group of CSE, there were a total of
30 patients who were candidates for anticoagulation, and among those, 14 (14/30; 46.6%) were
anticoagulated, but only 6 (6/30; 20%) were within therapeutic range at the time of their stroke.
Conclusions: Rheumatic valvular disease seems to be the most common CSE in Iran. Many patients with
rheumatic or non-rheumatic CSE are not adequately managed for prevention of cardioembolic stroke.
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Do¤u ‹ran’da Kardiyo Embolik ‹nmeler ve Romatizmal Kapak Hastal›¤›n›n
Önemi
Giriﬂ-Amaç: Romatizmal kapak hastal›klar› özellikle geliﬂmekte olan ülkelerde çocuklar›n romatizmal ateﬂ
hastal›¤›n›n en s›k komplikasyonudur. Yaﬂam›n sonraki evrelerinde, romatizmal kapak hastal›klar› inmeler için
en önemli de¤iﬂtirilebilir risk faktörüdür. ‹randa romatizmal kapak hastal›¤› insidans› ve komplikasyonlar› tam
olarak bilinmemektedir.
Yöntem ve Gereç: Bu çal›ﬂma ‹randa hemorajik olmayan inme tan›s›yla üçüncül bir referans hastanesine
baﬂvuran 302 hasta üzerinde yap›lm›ﬂ prospektif bir çal›ﬂmad›r. Hastalar›n tümü klinik endikasyonlara uygun
olarak inme etyolojisini saptamaya yönelik testlere tabii tutuldu. ‹nme tan›s› ve s›n›flamas› Dünya Sa¤l›k Örgütü
kriterlerine göre yap›ld›.
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Bulgular: ‹nme oldu¤u saptanan ortalama yaﬂ› 66.8(14) olan 302 hastan›n ortalama yaﬂ› 65.6(17.5) olan
60’›nda (%20) emboli kardiyak kaynakl› idi(CSE). Bu kardiyoembolik inme olan hastalar›n 28’inde (28/60)
romatizmal mitral darl›¤› mevcuttu. Kalan 32 hasta (%53)da di¤er kardiyak nedenler mevcuttu. Bu son
gruptaki hastalar›n 8’inde (%25) valvüler olmayan atriyal fibrilasyon mevcuttu. CSE grubundaki hastalar›n
30’u antikoagülasyona adayd› ve bunlar›n da 14’ü antikoagülan al›yordu ancak inme an›nda bunlar›n sadece 6’s›
tedavi edici dozlarda ilaç almaktayd›.
Sonuç: ‹randa en s›k görülen CSE romatizmal kapak hastal›klar›d›r. ‹ster romatizmal ister romatizmal olmayan
nedenlerle olsun hastalar›n ço¤u kardiyoembolik inmeleri önlemeye yönelik uygun tedavi almamaktad›r.
Anahtar Sözcükler: Kardiyoemboli, ‹nme, Romatizma

kavianghandehari@yahoo.com
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Introduction
While one-fourth of strokes are cardioembolic, cardiac
source of embolism (CSE) is considered as a modifiable
risk factor of stroke. The distribution of cardiac
pathology as the cause of embolic stroke varies among
countries. While in the developed countries non-valvular
atrial fibrillation is the most prevalent, in developing
countries rheumatic valvular disease continues to prevail
as the most common cause of CSE (1). Data regarding
the incidence and prevalence of rheumatic heart disease in
developing countries are lacking (2). Adequate
anticoagulation offers stroke prevention in patients with
rheumatic valvular disease or other potential CSE.
In developing countries, prevention of rheumatic
valvular disease and its complications is inadequate (2).
The incidence of stroke complicating rheumatic valvular
disease is in the range of 1.5% to 4.7% (3).
Unfortunately, epidemiologic studies on rheumatic
valvular disease and its complications are lacking in Iran.
However, many tertiary care centers are involved with
managing the complications of this preventable childhood
disease. Herein we present our experience with CSE in a
tertiary care center in Iran.

Materials and Methods
Valie-Asr hospital is a tertiary care university hospital
in Khorasan, Iran, and it serves a population of 400,000.
From June 2003 to June 2005, all consecutive patients
admitted to this hospital with a diagnosis of nonhemorrhagic stroke were included into this prospective
observational study.
All of the patients were seen by a stroke specialist.
Stroke was defined and classified according to World
Health Organization (WHO) criteria (4.5). Patients
underwent a standard battery of diagnostic
investigations, including brain computed tomography
(CT), ECG, blood electrolytes, blood count and
differential, coagulation profile, carotid Doppler, transthoracic echocardiogram, fasting blood glucose and lipid
profile. Trans-esophageal echocardiogram was obtained
in patients in whom trans-thoracic echocardiogram was
non-diagnostic despite high suspicion of CSE. A 24-hour
Holter monitoring was obtained in patients with history
of syncope and/or palpitation or high suspicion of CSE
with non-diagnostic echocardiography and ECG. Three
serial blood cultures were requested for any stroke
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patient with fever and heart murmur or valvular
vegetation detected by echocardiography. Data on patient
demographics, clinical presentation, and diagnostic workup were recorded in a database.
Statistical methods: Results were expressed as mean
with standard deviation for quantitative variables and
number with percentage for qualitative variables.
Univariate analysis was done by using independent sample
t-test, Mann-Whitney U test, and Pearson chi-square test,
whenever appropriate. P-value less than 0.05 was
considered as statistically significant.

Results
From June 2003 to June 2005, non-hemorrhagic
stroke was diagnosed in 302 patients (159 female, 143
male). CSE was diagnosed in 60 (19.8%) of these
patients, and 37 (61.6%) of them were female. Mean age
of the group with CSE was 65.61; SD: 17.48. The mean
age of female patients was 64.59; SD: 2.80, and of male
patients was 67.26; SD: 3.83.
Among patients with cardioembolic stroke, rheumatic
valvular disease was detected in 28 (28/60; 46.6%), and
of those, 19 (19/28; 67.8%) had atrial fibrillation. The
remaining 32 (32/60; 53.3%) cardioembolic stroke
patients had other types of CSE. In the latter group, 8
(8/32; 25%) patients had non-valvular atrial fibrillation.
The frequency rate of various CSE in our 60
cardioembolic stroke patients is illustrated in Table.
In the rheumatic valvular disease group, there were
significantly more female patients (OR = 2.34, CI = 0.976.24, P-value = 0.036). Gender was not a significant
factor in the non-rheumatic CSE group (OR = 1.02, CI =
0.46-2.26, P-value = 0.89). The average age of female
patients in the rheumatic valvular disease group was
59.30, SD: 16.6, and of male patients was 61.12, SD:
17.54, with no significant difference between the two
genders (P = 0.899). The average age of female patients
in the non-rheumatic CSE group was 70.82, SD: 15.82,
and of male patients was 70.53; SD: 18.59, with no
significant difference between the two genders (P =
0.894). There was no significant difference in the
number of patients referred from urban or rural
dwellings in the rheumatic CSE group; OR = 1.0, CI =
0.45-2.31, P = 0.96.
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Table. Cardiac source of emboli in 60 cardioembolic stroke patients.
Cardiac Disorders
Valvular Atrial Fibrillation (VAF)
Non-valvular Atrial Fibrillation (NVAF)
Mechanical Mitral Valve (1 with VAF)
Mitral Annular Calcification
Rheumatic Mitral Stenosis (18 with VAF)
Mitral Valve Prolapse
Nonbacterial Endocarditis
Left Ventricular Thrombus
Acute Myocardial Infarction (1 with NVAF)
Left Ventricular Aneurysm
Left Ventricular Akinetic Segment
Congestive Heart Failure (1 with NVAF)
Patent Foramen Ovale
All Cardiac Sources of Emboli

In the rheumatic valvular disease group, 24 patients
were candidates for anticoagulation; however, only 11
(11/24; 45.8%) were anticoagulated, and among those
only 5 patients (5/24; 20.8%) had international
normalized ratio (INR) within therapeutic range. Among
the non-rheumatic patients, 6 were candidates for
anticoagulation; however, only 3 (3/6; 50%) were
anticoagulated, and only 1 (1/6; 16.6%) was within
therapeutic range. In the entire group of CSE, there were
total of 30 patients who were candidates for
anticoagulation, and among those, 14 (14/30; 46.6%)
were anticoagulated, but only 6 (6/30; 20%) were within
therapeutic range.

Discussion
The incidence of CSE in our stroke patients was
19.8%. Cardioembolic strokes represented 14% of the
Stroke Data Bank (6) and 20% of the Lausanne Stroke
Registry (7). Almost half of the cardioembolic strokes in
developed countries are secondary to non-valvular atrial
fibrillation and 7.6% of CSE is due to rheumatic heart
disease (8). Rheumatic heart disease is an important
cause of mitral and aortic valve disease in developing
countries (9,10,11). Rheumatic valvular disease was
present in 46.6% of CSE in our cardioembolic stroke
patients and in 70.3% of the atrial fibrillations. Cardiac
disease was found in 23% of Ethiopian stroke patients
and valvular heart disease accounted for 40% of all

Female

Male

Total

12
4
1
2
7
7
1
2
1
37

7
4
1
2
1
1
1
1
1
4
23

19
8
1
2
8
9
2
1
1
1
1
6
1
60

heart disease in the stroke patients (12). Rheumatic
valvular disease was found in 44.8% of the patients
with cardioembolic stroke and in 63.5% of fibrillating
stroke patients in the Khorasan stroke registry (13).
The incidence of rheumatic valvular disease in our
stroke patients was 9.3% (28/302), and was
significantly higher in females. This is in agreement with
previous reports (14,15). The cause of this gender
discrepancy is unknown (14,15). In Iran, epidemiologic
studies on rheumatic heart disease are lacking.
Therefore, data on early diagnosis and management of
streptococcal throat infection and its complications are
not available. Further improvement in the quality of the
manufacturing and storage of antibiotics is
recommended in developing countries (2). Clear
indications for anticoagulant therapy are identified in
patients with CSE (16,17); however, adequate
anticoagulation was achieved in 20% of our patients
who were candidates for this treatment. The reasons
for this inadequate management of CSE are unknown,
though inadequacies in logistics and infrastructure may
be among the contributing factors.
Through our study we opened only a small window
to evaluate rheumatic valvular disease as a public health
concern. Much work is required with respect to the
epidemiology and prevention of rheumatic valvular
disease and its complications in Iran and other developing
countries.
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